IFNA1 and systemic lupus erythematosus: A sustained IFN-mediated inflammation eventually increases dendritic cell activation, plasma cell maturation, and autoantibody production, favoring the development of IFN-associated autoimmunity disorders, as in SLE, dermatomyositis, or Sjogren’s syndrome [31,32,33,34,35,36].